Asia-Pacific Gastroparesis Market to Grow at a CAGR of 4.9% to reach US$ 1,623.77 million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia-Pacific Gastroparesis Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia-Pacific Gastroparesis Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing prevelance of Diabetes Mellitus

5.2 Market Opportunities

5.2.1 Surging Clinical Trials

5.3 Future Trends

5.3.1 Technological Advancements and incresaing research on gastric stimulation

5.4 Impact of Drivers and Restraints

6. Asia-Pacific Gastroparesis Market Regional Analysis

6.1 Asia-Pacific Gastroparesis Market Overview

6.2 Asia-Pacific Gastroparesis Market Revenue 2018-2027 (US$ Million)

6.3 Asia-Pacific Gastroparesis Market Forecast Analysis

7. Asia-Pacific Gastroparesis Market Analysis – by Type

7.1 Idiopathic

7.1.1 Overview
7.1.2 Idiopathic: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Diabetic

7.2.1 Overview
7.2.2 Diabetic: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Post-Surgical

7.3.1 Overview
7.3.2 Post-Surgical: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia-Pacific Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents

8.1.1 Overview
8.1.2 Prokinetic Agents: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Botulinum Toxin Injections

8.2.1 Overview
8.2.2 Botulinum Toxin Injections: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Antiemetic Agents

8.3.1 Overview
8.3.2 Antiemetic Agents: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia-Pacific Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Antiemetic Agents: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Antiemetic Agents: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia-Pacific Gastroparesis Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia-Pacific Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
10.1.1.1 Asia-Pacific Gastroparesis Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 China: Asia-Pacific Gastroparesis Market Breakdown, by Type
10.1.1.1.2 China: Asia-Pacific Gastroparesis Market Breakdown, by Drug Class
10.1.1.1.3 China: Asia-Pacific Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.2 India: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 India: Asia-Pacific Gastroparesis Market Breakdown, by Type
10.1.1.2.2 India: Asia-Pacific Gastroparesis Market Breakdown, by Drug Class
10.1.1.2.3 India: Asia-Pacific Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.3 Japan: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Japan: Asia-Pacific Gastroparesis Market Breakdown, by Type
10.1.1.3.2 Japan: Asia-Pacific Gastroparesis Market Breakdown, by Drug Class
10.1.1.3.3 Japan: Asia-Pacific Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.4 Australia: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Australia: Asia-Pacific Gastroparesis Market Breakdown, by Type
10.1.1.4.2 Australia: Asia-Pacific Gastroparesis Market Breakdown, by Drug Class
10.1.1.4.3 Australia: Asia-Pacific Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.5 Rest of Asia-Pacific: Asia-Pacific Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific: Asia-Pacific Gastroparesis Market Breakdown, by Type
10.1.1.5.2 Rest of Asia-Pacific: Asia-Pacific Gastroparesis Market Breakdown, by Drug Class
10.1.1.5.3 Rest of Asia-Pacific: Asia-Pacific Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia-Pacific Gastroparesis Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allergan Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ipca Laboratories Ltd.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson and Johnson Services, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Pfizer Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights